Intelligence Feed event · Commodity · 2026-10-01

    Albemarle Declines to $105.78, Deepening One-Month Drop to 20.6%

    Question

    Albemarle Declines to $105.78, Deepening One-Month Drop to 20.6%

    Direct answer

    Albemarle shares fell 1.71% to $105.78 as chemical producers continued to underperform broader equity benchmarks. Over the past month, the stock's 20.6% loss has significantly outpaced the broader sector, reflecting persistent investor focus on upstream commodity price realizations and conversion margins.

    Original publisher
    Market Ontology
    Evidence through
    2026-10-01
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Albemarle Declines to $105.78, Deepening One-Month Drop to 20.6%”, revision 1, evidence through 2026-10-01. https://marketontology.com/market-events/2026-10-01/albemarle-declines-to-105-78-deepening-one-month-drop-to-20-6-ffbefd

    COMMODITY
    Albemarle Declines to $105.78, Deepening One-Month Drop to 20.6%
    Albemarle shares fell 1.71% to $105.78 as chemical producers continued to underperform broader equity benchmarks. Over the past month, the stock's 20.6% loss has significantly outpaced the broader sector, reflecting persistent investor focus on upstream commodity price realizations and conversion margins.
    ALBSPY
    Impact
    61
    OCT 1
    SIG
    85%
    ALBSPY
    Albemarle Declines to $105.78, Deepening One-Month Drop to 20.6%
    Albemarle shares fell 1.71% to $105.78 as chemical producers continued to underperform broader equity benchmarks. Over the past month, the stock's 20.6% loss has significantly outpaced the broader sector, reflecting persistent investor focus on upstream commodity price realizations and conversion margins.
    → Depressed spot lithium pricing compresses realized chemical sales realizations, pressuring ALB equity valuation despite projected revenue increases.
    Impact
    Albemarle shares fell 1.71% to $105.78 as chemical producers continued to underperform broader equity benchmarks. Over the past month, the stock's 20.6% loss has significantly outpaced the broader sector, reflecting persistent investor focus on upstream commodity price realizations and conversion margins.
    Affected
    ALBSPY
    Transmission
    Depressed spot lithium pricing compresses realized chemical sales realizations, pressuring ALB equity valuation despite projected revenue increases.

    How this development reaches the affected companies

    AssetExposure and channelDirectionEvidence
    ALBspecialty chemicals margin compression from lithium pricing headwindsDown1-4wStock dropped 20.6% in 30 days, underperforming specialty chemicals sector benchmark.
    SPYmaterials sector beta drag on broader index performanceWatchintradayS&P 500 slipped 0.25% as specialty materials faced selling pressure.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    AssetCallBase close+1 day+5 days+20 days
    SPYWatch763.99 2026-10-01+0.74%+1.30%Pending

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month